The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Hezkue 12.5 mg/actuation, oral suspension



Aspargo Labs Ireland LimitedPA25240/001/001

Main Information

Trade NameHezkue 12.5 mg/actuation, oral suspension
Active SubstancesSildenafil citrate
Dosage FormOral suspension
Licence HolderAspargo Labs Ireland Limited
Licence NumberPA25240/001/001

Group Information

ATC CodeG04BE03 sildenafil

Status

License statusAuthorised
Licence Issued12/08/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back